Loading...
•
Dec 31, 2024
Ashland Q1 2025 Earnings Report
Ashland's financial performance in Q1 2025 was impacted by portfolio optimization and softer market conditions.
Key Takeaways
Ashland reported sales of $405 million, a 14% decrease compared to the prior-year quarter. The company experienced a net loss of $165 million, or $3.50 per diluted share. Adjusted EBITDA was $61 million, down 13% from the prior-year quarter. The company is maintaining its full-year fiscal 2025 outlook.
Sales decreased by 14% year-over-year to $405 million, with Portfolio Optimization reducing sales by approximately $50 million or 11%.
Loss from continuing operations was $166 million, or a loss of $3.51 per diluted share.
Adjusted income from continuing operations excluding intangibles amortization expense was $14 million, or $0.28 per diluted share.
Adjusted EBITDA decreased by 13% year-over-year to $61 million, with Portfolio Optimization reducing Adjusted EBITDA by approximately $8 million or 11%.
Revenue by Segment
Forward Guidance
Ashland continues to expect full fiscal year sales in the range of $1.90 billion to $2.05 billion and Adjusted EBITDA in the range of $430 million to $470 million.
Positive Outlook
- Expanding high-performing business lines into new markets
- Commercializing new technology platforms
- Accelerating cost savings
- Optimizing its portfolio through the planned sale of Avoca
- Well-positioned to deliver on our goals with high-impact, self-help efforts underway
Challenges Ahead
- Weaker demand in Europe
- Effects of extended plant shutdowns
- Monitoring a potential European recovery
- Trade policy shifts
- Uncertainty surrounding potential trade policy changes
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...